LOINC
Version 2.73

87439-6Zika virus IgA+IgG+IgM Ab [Interpretation] in Specimen Qualitative by ImmunoassayActive

Term Description

Overall qualitative result for Zika virus antibody (IgG,IgM,IgA) based on an algorithm that considers individual quantitative results for antibodies to various target antigens. This term was created for, but not limited in use to, a Flavivirus multiplex microsphere immunofluorescence assay (MIA) performed by the New York State Department of Health.
Source: Regenstrief LOINC

Part Description

LP200137-0   Zika virus
Zika virus (ZIKV) is a flavivirus transmitted primarily by the Aedes mosquito which was first identified in a sentinel monkey in the Zika forest in Uganda in 1947. Since 2014 it has spread explosively in the Americas where it has infected hundreds of thousands of people. About 80% of those infected are asymptomatic. Common symptoms include fever, headache, rash, arthralgia and conjunctivitis. Since the end of 2015, there has been an increase in ZIKV-associated cases of Guillain-Barre syndrome and a tremendous increase in cases of microcephaly in fetuses and newborns in Brazil, raising worldwide public health concern. Recent predictions are that the mosquito species A. Albopictus, which can hibernate and survive cool temperatures, will carry ZIKV to more temperate areas of North America, Australia and Southern Europe. It is still not clear whether ZIKV in humans increases viral titers enough to trigger a new cycle when an infected person is bitten by a naïve mosquito. Direct human-to-human transmission has been documented to occur perinatally, sexually (primarily through semen), through breastfeeding, blood transfusion and through occupational transmission in the laboratory setting. There are currently no specific anti-viral agents, vaccination or medical prophylaxis available. [PMID:27148186] Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Regenstrief LOINC, PMID: 27148186

Fully-Specified Name

Component
Zika virus Ab.IgA+IgG+IgM
Property
Imp
Time
Pt
System
XXX
Scale
Ord
Method
IA

Additional Names

Short Name
ZIKV IgA+IgG+IgM Spec IA-Imp
Display Name
ZIKV IgA+IgG+IgM IA Ql (Specimen) [Interp]
Consumer Name Alpha
Zika virus IgA+IgG+IgM, Specimen

Example Answer List LL2017-3

Source: Siemens

Answer Code Score Answer ID
Indeterminate Copyright http://snomed.info/sct ID:82334004 Indeterminate (qualifier value) LA11884-6
Reactive Copyright http://snomed.info/sct ID:11214006 Reactive (qualifier value) LA15255-5
Nonreactive Copyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value) LA15256-3

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.63
Last Updated
Version 2.69
Order vs. Observation
Both

Member of these Panels

LOINC Long Common Name
87441-2 Dengue virus 1+2+3+4 and Zika virus IgA+IgG+IgM panel - Specimen by Immunoassay

Member of these Groups

LG32774-8 Zika virus

Language Variants Get Info

zh-CNChinese (China)
寨卡病毒 抗体.IgA+IgG+IgM:印象:时间点:XXX:序数型:免疫测定法
nl-NLDutch (Netherlands)
zikavirus As.IgA + IgG + IgM:interpretatie:moment:XXX:ordinaal:immunoassay
fr-FRFrench (France)
Zika virus Ac IgA+IgG+IgM:Interprétation:Ponctuel:Milieux divers:Qualitatif:Immunoanalyse
de-DEGerman (Germany)
Zika-Virus Ak.IgA+IgG+IgM:Interpretation:Zeitpunkt:XXX:Ordinal:Immunoassay
it-ITItalian (Italy)
Zika virus Ab.IgA+IgG+IgM:Imp:Pt:XXX:Ord:IA
es-MXSpanish (Mexico)
Ab.IgA + IgG + IgM del virus del Zika:Impresión / interpretación del estudio:Punto temporal:XXX:Ordinal:Inmunoensayo
es-ESSpanish (Spain)
Virus Zika IgA+IgG+IgM:Impresión/interpretación del estudio:Punto temporal:XXX:Ord:IA
tr-TRTurkish (Turkey)
Zika virüs Ab.IgA+IgG+IgM:İzlnm:Zmlı:XXX:Srl:İA

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=87439-6